Programmed Cell Death In The Nervous System
Programmed Cell Death In The Nervous System
批准号:
10688926
负责人:
Richard James Youle
金额:
$54.7万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AcanthocytosisApoptosisArtificial IntelligenceBCL2 geneBiochemicalBiogenesisBiologicalCRISPR screenCell DeathCell membraneCellsCellular biologyChoreaCohen syndromeCytosolDevelopmentDiseaseDissectionDrug TargetingEmbryoEndoplasmic ReticulumEssential GenesEventFamily memberFlow CytometryGenesGeneticGuide RNAHomologous GeneHumanImageInflammationIntracellular translocationInvestigationKnock-outLightLinkLysosomesMammalsMediatingMembraneMethodologyMicroscopyMitochondriaMitochondrial DNAMorphologyMovement DisordersMusMutationNervous SystemNeurodegenerative DisordersNeurodevelopmental DisorderNeuronsNuclearOrganellesParkinson DiseasePathologicPathway interactionsPatientsPhenotypeProcessProtein FamilyProteinsRoleSiteSpinocerebellar AtaxiasStimulator of Interferon GenesWorkYeastsartificial intelligence algorithmautism spectrum disorderbaseconstrictionflygene productgenome wide association studygenome-wideinterestlipid transportloss of functionneurodegenerative phenotypeneuron lossnovelperoxisomescreeningstem
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We have studied programmed cell death in the nervous system and the biochemical mechanisms of apoptosis. The Bcl-2 family of proteins regulate the survival of neurons during development. We previously discovered that one member of this family, Bax, migrates from the cytosol to the cell membranes as a key commitment point of neuron death. Interestingly, Bax coalesces into large aggregates at mitochondrial constriction sites and mitochondrial fission sites. How this is initiated is unknown and identifying novel steps could serve as drug targets to inhibit neuron death. To interrogate this step in more detail we have explored how mitochondria divide in healthy and dying cells and developed a new screen of intracellular translocation events.
1) Mitochondria form contacts with other intracellular organelles including the endoplasmic reticulum (ER), peroxisomes and lysosomes. Mitochondrial ER contact sites are involved in mitochondrial fission, at the precise sites where Bax coalesces. In yeast, Vps13 has been linked to mitochondria ER membrane contact sites and it appears to mediate lipid transport between the two organelles. Mammals have four VPS13 homologues: VPS13A-D. Mutations in VPS13A cause the neurodegenerative disease chorea-acanthocytosis. VPS13B is associated with Cohen syndrome, a neurodevelopmental disorder that shares features with autism. Genome-wide association studies show loss of function VPS13C mutations cause Parkinson's disease. VPS13D mutations are linked to movement disorders classified as a subtype of spinocerebellar ataxia, spinocerebellar ataxia autosomal recessive 4 (SCAR4). In contrast to VPS13A-C, VPS13D is considered an essential gene in human cells and complete loss of VPS13D causes embryonic lethality in mice and flies. We investigated the cellular biology of VPS13A-D knockout (KO) in human cells and found a dual role for VPS13D in mitochondrial morphology and peroxisome biogenesis. This contrasts with the other three Vps13 genes and identifies a new biological role of this SCAR4 gene. Most recent work of ours and others shows that loss of Vps13C or loss of Vps13D is linked to inflammation. We will explore how this may stem from mitochondrial disfunction, release of mitochondrial DNA into the cytosol to activate the cGAS STING inflammation pathway and how inflammation may be associated with the neurodegenerative phenotypes of Vps13C-D patients.
2) To uncover how the apoptosome functions downstream of Bax translocation to mitochondria to mediate cell death we developed a new CRISPR screening platform that allows genetic dissection of Bax translocation and other cell translocation events based on light imaging. Cells are screened by using microscopy and classified by artificial intelligence (AI) algorithms, which precisely identify the genetically altered phenotype. Cells with the phenotype of interest are photoactivated and isolated via flow cytometry, and the gRNAs are identified by sequencing. We are currently using this new platform to screen for genes involved in assembly if the apoptosome relative involved in inflammation, NLRP3, and to screen for genes involved in peroxisome biogenesis and peroxisome biogenesis disorder-Zellweger spectrum disorder (PBD-ZSD) related genes. This approach, AI-photoswitchable screening (AI-PS), offers a novel screening platform capable of classifying a broad range of mammalian subcellular morphologies, an approach largely unattainable with current methodologies at genome-wide scale.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Engineering Cell Type Specific Toxins
-
批准号:7323060
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Mechanisms of Autophagy
-
批准号:8557093
-
项目类别:
-
资助金额:$67.33万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Role of mitochondria in neurodegenerative diseases
-
批准号:8342293
-
项目类别:
-
资助金额:$181.11万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Programmed Cell Death In The Nervous System
-
批准号:6990654
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Role of mitochondria in neurodegenerative diseases
-
批准号:8746848
-
项目类别:
-
资助金额:$204.9万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Role of mitochondria in neurodegenerative diseases
-
批准号:9563160
-
项目类别:
-
资助金额:$112.91万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Programmed Cell Death In The Nervous System
-
批准号:7735271
-
项目类别:
-
资助金额:$159.85万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Central Nervous System Drug Delivery Techniques
-
批准号:10018688
-
项目类别:
-
资助金额:$30.56万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Neuro-oncology of Familial Neoplasia Syndromes
-
批准号:10018690
-
项目类别:
-
资助金额:$79.14万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Role of mitochondria in neurodegenerative diseases
-
批准号:10688932
-
项目类别:
-
资助金额:$171.83万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Mechanisms of Autophagy
-
批准号:10915983
-
项目类别:
-
资助金额:$188.26万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Central Nervous System Drug Delivery Techniques
-
批准号:10253920
-
项目类别:
-
资助金额:$30.88万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Mechanisms of Autophagy
-
批准号:10265219
-
项目类别:
-
资助金额:$60.23万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Molecular Pathogenesis of Neoplasia
-
批准号:8940096
-
项目类别:
-
资助金额:$101.99万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Programmed Cell Death In The Nervous System
-
批准号:8557014
-
项目类别:
-
资助金额:$101.0万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Molecular Pathogenesis of Neoplasia
-
批准号:9157542
-
项目类别:
-
资助金额:$100.21万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Programmed Cell Death In The Nervous System
-
批准号:9563103
-
项目类别:
-
资助金额:$65.03万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Programmed Cell Death In The Nervous System
-
批准号:9358539
-
项目类别:
-
资助金额:$80.87万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Neuro-oncology of Familial Neoplasia Syndromes
-
批准号:9563146
-
项目类别:
-
资助金额:$64.63万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
ENGINEERING CELL TYPE SPECIFIC TOXINS
-
批准号:6432897
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: